• ACM Biosciences AG

    BS
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-270.3.016.132-4
    Sector: Research and development

    Age of the company

    3 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    160'319

    Employees

    PremiumPremium

    Active brands

    0

    Reports for ACM Biosciences AG

    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company. Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company. Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices. Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings. Find out more
    preview

    Shareholder Information

    Find out which national and international companies the stock corporation you are interested in also holds shares in. Find out more

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About ACM Biosciences AG

    • ACM Biosciences AG with its legal headquarters in Basel is active. ACM Biosciences AG operates in the sector «Research and development».
    • The management of the company ACM Biosciences AG consists of 2 persons.
    • The most recent commercial register change was made on 16.08.2023. You can find all changes under «Notifications».
    • The company is registered in the commercial register BS under the UID CHE-137.061.516.
    • On the same address as ACM Biosciences AG there are 48 other active companies registered. These include: Alance Fassadenbau AG, ApiniLabs AG, Argo Therapeutics GmbH.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language) Customise the company purpose with just a few clicks.

    Der Zweck der Gesellschaft ist Erforschung, Entwicklung, Herstellung und Vertrieb von pharmazeutischen und verwandten Produkten aller Art. Die Gesellschaft kann in- und ausländische Gesellschaften und Niederlassungen errichten, in in- und ausländische Gesellschaften investieren, andere Gesellschaften und Liegenschaften kaufen, verwalten und verkaufen sowie Finanzaktivitäten durchführen.

    Auditor

    Source: SOGC

    Former auditor (1)
    Name City Since Until
    Ernst & Young AG
    Basel 16.09.2020 01.05.2023

    Other company names

    Source: SOGC

    Es sind keine früheren oder übersetzten Firmannamen vorhanden.

    Would you like to update the company name? Click here.

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: ACM Biosciences AG

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 230816/2023 - 16.08.2023
    Categories: Change in management

    Publication number: HR02-1005817587, Commercial Registry Office Basel-Stadt, (270)

    ACM Biosciences AG, in Basel, CHE-137.061.516, Aktiengesellschaft (SHAB Nr. 84 vom 02.05.2023, Publ. 1005736809).

    Ausgeschiedene Personen und erloschene Unterschriften:
    Breidenbach, Alexander, deutscher Staatsangehöriger, in Weil am Rhein (DE), mit Kollektivunterschrift zu zweien.

    SOGC 230502/2023 - 02.05.2023
    Categories: Change in management, Change of auditors

    Publication number: HR02-1005736809, Commercial Registry Office Basel-Stadt, (270)

    ACM Biosciences AG, in Basel, CHE-137.061.516, Aktiengesellschaft (SHAB Nr. 22 vom 01.02.2023, Publ. 1005666981). Gemäss Erklärung vom 18.04.2023 wurde auf die eingeschränkte Revision verzichtet.

    Ausgeschiedene Personen und erloschene Unterschriften:
    Ernst & Young AG (CHE-105.932.265), in Basel, Revisionsstelle.

    Eingetragene Personen neu oder mutierend:
    Nallani Padmanabha Naidu, Madhavan, singapurischer Staatsangehöriger, in Singapore (SG), Mitglied des Verwaltungsrates, mit Einzelunterschrift [bisher: Präsident des Verwaltungsrates, mit Einzelunterschrift].

    SOGC 230201/2023 - 01.02.2023
    Categories: Change of company address

    Publication number: HR02-1005666981, Commercial Registry Office Basel-Stadt, (270)

    ACM Biosciences AG, in Basel, CHE-137.061.516, Aktiengesellschaft (SHAB Nr. 189 vom 29.09.2022, Publ. 1005571718).

    Domizil neu:
    Aeschenplatz 6, 4052 Basel.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm